Hemanext gets CE mark for RBC processing and storage system

Hemanext ONE is beneficial for people with sickle cell disease (SCD), thalassaemia, and myelodysplastic syndromes (MDS). (Credit: Crystal Blair from Pixabay)



Related Article
Recommended Whitepaper

View More